- Home
- YOUL vs GNLX Comparison
YOUL vs GNLX Comparison
Compare YOUL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOUL
- GNLX
- Stock Information
- Founded
- YOUL N/A
- GNLX 2001
- Country
- YOUL China
- GNLX United States
- Employees
- YOUL N/A
- GNLX N/A
- Industry
- YOUL Other Consumer Services
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- YOUL Real Estate
- GNLX Health Care
- Exchange
- YOUL Nasdaq
- GNLX Nasdaq
- Market Cap
- YOUL 131.6M
- GNLX 128.0M
- IPO Year
- YOUL N/A
- GNLX 2023
- Fundamental
- Price
- YOUL $1.95
- GNLX $7.64
- Analyst Decision
- YOUL
- GNLX Strong Buy
- Analyst Count
- YOUL 0
- GNLX 5
- Target Price
- YOUL N/A
- GNLX $17.40
- AVG Volume (30 Days)
- YOUL N/A
- GNLX 226.4K
- Earning Date
- YOUL N/A
- GNLX 11-13-2025
- Dividend Yield
- YOUL N/A
- GNLX N/A
- EPS Growth
- YOUL N/A
- GNLX N/A
- EPS
- YOUL N/A
- GNLX N/A
- Revenue
- YOUL N/A
- GNLX N/A
- Revenue This Year
- YOUL N/A
- GNLX N/A
- Revenue Next Year
- YOUL N/A
- GNLX N/A
- P/E Ratio
- YOUL N/A
- GNLX N/A
- Revenue Growth
- YOUL N/A
- GNLX N/A
- 52 Week Low
- YOUL N/A
- GNLX $1.99
- 52 Week High
- YOUL N/A
- GNLX $8.27
- Technical
- Relative Strength Index (RSI)
- YOUL N/A
- GNLX 73.44
- Support Level
- YOUL N/A
- GNLX $7.05
- Resistance Level
- YOUL N/A
- GNLX $8.26
- Average True Range (ATR)
- YOUL 0.00
- GNLX 0.70
- MACD
- YOUL 0.00
- GNLX 0.19
- Stochastic Oscillator
- YOUL 0.00
- GNLX 82.17
About YOUL Youlife Group Inc. American Depositary Shares
Youlife Group Inc is a blue-collar lifetime service provider with a nationwide network of 25 vocational schools under school management model and 25 curriculum development projects, covering a total of 37 cities or counties under 16 provinces of China.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.